Jazz Pharmaceuticals JAZZ Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's operating lease ROU assets?
- Jazz Pharmaceuticals (JAZZ) reported operating lease ROU assets of $55.8M in Q1 2026.
- How has Jazz Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Jazz Pharmaceuticals's operating lease ROU assets increased by 13.5% year-over-year, from $49.18M to $55.8M.
- What is the long-term trend for Jazz Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's operating lease ROU assets has grown at a -14.5% compound annual growth rate (CAGR), from $129.17M to $58.9M.
- What does operating lease ROU assets mean?
- The value of the company's right to use leased property like offices or labs.
- How do you interpret operating lease ROU assets?
- An increase indicates expansion of leased facilities, while a decrease suggests consolidation or lease expirations.
- How does operating lease ROU assets compare across companies?
- Standardized under ASC 842; comparable across all companies with significant real estate footprints.